Navigation Links
Actavis Launches Carvedilol Tablets in the U.S.
Date:9/5/2007

ents to differ materially from that expressed or implied by these forward-looking statements. These factors include, among other things, exchange rate fluctuations, the risk that research and development will not yield new products that achieve commercial success, the impact of competition, price controls and price reductions, the risk of loss or expiration of patents or trade marks, difficulties of obtaining and maintaining governmental approvals for products, the risk of substantial product liability claims, exposure to environ


'/>"/>
SOURCE Actavis Group
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Glaxo launches pills to help smokers quit in 7-12 weeks
2. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
3. Dr Reddy’s Laboratories launches Hyalosy
4. Serum Institute Launches New Tetanus-Diphtheria Vaccine
5. Scottish Health Minister Launches Organ Donor Plan
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Pfizer Launches Viagra For Lung Disease In UK
8. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
9. PM Launches Healthcare Foundation For India
10. African Union Launches A Programme On Acceleration of HIV Prevention
11. Yale School of Medicine Launches Telemonitoring Of Heart Failure Symptoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2014)... Robins & Morton received nine Excellence ... Contractors (ABC) of Alabama. , ABC will recognize ... Sheraton Birmingham Hotel., ,     HealthSouth Rehabilitation ... $25 Million, Obelisk Award (First Place) , ... Million to $25 Million, Obelisk Award (First Place) ...
(Date:10/2/2014)... HealthDay Reporter WEDNESDAY, Oct. ... control -- especially long-acting implanted devices -- could slash pregnancy ... new findings suggest. In a study of 1,400 teenage ... the girls, rates of unplanned pregnancy and abortion. Over three ... -- versus a rate of 158 per 1,000 among all ...
(Date:10/2/2014)... 1, 2014 (HealthDay News) -- Children with autism are ... fully capable of being more active, a small study ... of 29 children, some with autism and some without. ... of moderate physical activity and 70 more minutes each ... children with autism scored lower on strength, but had ...
(Date:10/2/2014)... Dennis Thompson HealthDay Reporter ... that pull out all the stops to rescue surgical ... but the cost of such heroism is questionable, a ... 5 percent better at saving elderly patients with life-threatening ... with less intensity, said senior author Dr. Amir Ghaferi. ...
(Date:10/1/2014)... strongly associated with Alzheimer,s disease; however, researchers are still ... causal agent of the onset and development of the ... beta-amyloid is not harmful when found in isolation but ... to form the so-called amyloid fibrils , "We are ... with multiple ones because each aggregate of peptide, which ...
Breaking Medicine News(10 mins):Health News:Robins & Morton wins nine awards from Associated Builders and Contractors 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 2Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 3Health News:Free, Long-Acting Contraceptives May Greatly Reduce Teen Pregnancy Rate 4Health News:Kids With Autism Tend to Be Less Active, Study Says 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 2Health News:'High-Intensity' Hospitals Save More Elderly After Surgery: Study 3Health News:Laying siege to beta-amyloid, the key protein in Alzheimer's disease 2
... IntraHealth International will highlight its ... the developing world during the 36th annual ... D.C., May 26-30. Hosted by the Global Health ... = Healthy Communities," focuses on the ways in which ...
... groups, headed by Prof. Nils Brose of the Max Planck ... on behalf of the European Union, to study the role ... the research teams is headed by Prof. Kobi Rosenblum of ... has been awarded a grant of 600,000 Euro. The topic ...
... reports MS medication possession ratio of 86 percent for ... Multiple sclerosis patients managed by a specialty pharmacy program ... risk of being hospitalized for their disease than those ... according to a study completed by HealthCore, Inc.HealthCore researcher ...
... Velocity,s intelligent search capabilities such as geo-spatial search, content ... May 19 Vivisimo ( www.vivisimo.com ), a leading ... that Bupa, an international health and care company with ... selected the Vivisimo Velocity Search Platform ...
... to provide sun protection, laughs and college scholarship ... Today non-profit Cancer for College launches a new ... proceeds from the sunscreen sales will go to ... granting college scholarships to cancer survivors and amputees.To ...
... mice might explain progression from skin to breathing condition ... secreted by eczema-damaged skin might trigger asthma in children, ... study of mice with an eczema-like condition, which suggested ... trigger substance might help prevent asthma. , An estimated ...
Cached Medicine News:Health News:IntraHealth International Addresses Capacity Building and Open Source Technologies at Tech-Themed Global Health Conference 2Health News:MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR 2Health News:MS Patients More Compliant with Medications When Managed by Specialty Pharmacy, According to HealthCore Study Presented at ISPOR 3Health News:Vivisimo Powers Site Search on Bupa's Leading Health Information Websites Worldwide 2Health News:Photos: Will Ferrell Sunscreen to Launch Just in Time for Summer 2Health News:Molecule in Skin May Link Eczema and Asthma 2
(Date:10/2/2014)... Research and Markets  has announced the ... by Application, and by Geography - Global Forecast to ... The medical electronics market is expected to grow at ... the world due to growing income levels, and increasing ... hypertension, and cardiovascular diseases. A growing population coupled with ...
(Date:10/2/2014)... 2, 2014  Eli Lilly and Company (NYSE: ... tabalumab­ -- being studied for the treatment of ... -- due to insufficient efficacy in two pivotal ... on safety concerns. ­­­­ In the ... primary endpoint, at either dose studied, of statistically ...
(Date:10/2/2014)...  InfinityQS International, Inc., the global authority on ... client speakers for Infusion Chicago, its 9 th ... will be held Oct. 9-10, 2014, at the ... from Coloplast, The Kellogg Company, Biomet, General Cable, ... two-day event will also include best practice presentations ...
Breaking Medicine Technology:Medical Electronics (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU) Market - Global Forecast to 2020 2Medical Electronics (Sensor, Battery, Memory Device, Display, & Microprocessor/MCU) Market - Global Forecast to 2020 3Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies 2Lilly to Discontinue Development of Tabalumab Based on Efficacy Results in Phase 3 Lupus Studies 3InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 2InfinityQS Infusion Chicago to Spotlight Manufacturers' Key Successes in Achieving Enterprise Quality 3
... SAN DIEGO, Oct. 4 To mark the beginning ... its breast cancer treatment services at its West Houston ... Emission Mammography) scanners are high-resolution breast PET systems that ... of a lesion.  The metabolic view allows physicians to ...
... ALTOONA, Pa., Oct. 4 In response ... and the importance of "aging-in-place" as an ... Technologies, LLC ("Delta") today announced the introduction ... developed to optimize the homecare therapist. ...
Cached Medicine Technology:SightLine Health Adds Naviscan PEM Technology to Breast Cancer Treatment Services 2Delta Health Technologies ClinicalVirtuoso™ Targets Homecare Therapists 2
IVUS console...
FemoStop system is a femoral compression system for hemostasis management. It provides a comfortable and efficient "hands off method of compressing the femoral artery and vein after diagnostic and i...
VasoSeal ES is a extravascular arterial sealing. It utilizes a unique temporary arterial locator system which provides an easier and surer method of locating the femoral artery....
... was the first device ... after diagnostic and interventional ... It is a collagen-based ... for immediate sheath removal ...
Medicine Products: